Your browser doesn't support javascript.
loading
The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella spp.
Fernández Álvaro, Elena; Voong Vinh, Phat; de Cozar, Cristina; Willé, David R; Urones, Beatriz; Cortés, Alvaro; Price, Alan; Tran Do Hoang, Nhu; Ha Thanh, Tuyen; McCloskey, Molly; Shaheen, Shareef; Dayao, Denise; Martinot, Amanda; de Mercado, Jaime; Castañeda, Pablo; García-Perez, Adolfo; Singa, Benson; Pavlinac, Patricia; Walson, Judd; Martínez-Martínez, Maria Santos; Arnold, Samuel L M; Tzipori, Saul; Ballell Pages, Lluis; Baker, Stephen.
Affiliation
  • Fernández Álvaro E; GSK Global Health, Tres Cantos, Madrid, Spain.
  • Voong Vinh P; The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.
  • de Cozar C; GSK Global Health, Tres Cantos, Madrid, Spain.
  • Willé DR; GSK R&D, Stevenage, United Kingdom.
  • Urones B; GSK Global Health, Tres Cantos, Madrid, Spain.
  • Cortés A; GSK Global Health, Tres Cantos, Madrid, Spain.
  • Price A; GSK Global Health, Tres Cantos, Madrid, Spain.
  • Tran Do Hoang N; The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.
  • Ha Thanh T; The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam.
  • McCloskey M; Division of Allergy and Infectious Disease, Center for Emerging and Re-emerging Infectious Diseases University of Washington School of Medicine, Seattle, United States.
  • Shaheen S; Division of Allergy and Infectious Disease, Center for Emerging and Re-emerging Infectious Diseases University of Washington School of Medicine, Seattle, United States.
  • Dayao D; Department of Infectious Disease and Global Health, Tufts University Cummings School of Veterinary Medicine, North Grafton, United States.
  • Martinot A; Department of Infectious Disease and Global Health, Tufts University Cummings School of Veterinary Medicine, North Grafton, United States.
  • de Mercado J; GSK Global Health, Tres Cantos, Madrid, Spain.
  • Castañeda P; GSK Global Health, Tres Cantos, Madrid, Spain.
  • García-Perez A; GSK Global Health, Tres Cantos, Madrid, Spain.
  • Singa B; Kenya Medical Research Institute, Nairobi, Kenya.
  • Pavlinac P; Department of Global Health, University of Washington, Seattle, United States.
  • Walson J; Division of Allergy and Infectious Disease, Center for Emerging and Re-emerging Infectious Diseases University of Washington School of Medicine, Seattle, United States.
  • Martínez-Martínez MS; GSK Global Health, Tres Cantos, Madrid, Spain.
  • Arnold SLM; Division of Allergy and Infectious Disease, Center for Emerging and Re-emerging Infectious Diseases University of Washington School of Medicine, Seattle, United States.
  • Tzipori S; Department of Infectious Disease and Global Health, Tufts University Cummings School of Veterinary Medicine, North Grafton, United States.
  • Ballell Pages L; GSK Global Health, Tres Cantos, Madrid, Spain.
  • Baker S; University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Elife ; 112022 03 15.
Article in En | MEDLINE | ID: mdl-35289746
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Shigella / Communicable Diseases / Anti-Infective Agents Limits: Animals / Child / Humans Language: En Journal: Elife Year: 2022 Type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Shigella / Communicable Diseases / Anti-Infective Agents Limits: Animals / Child / Humans Language: En Journal: Elife Year: 2022 Type: Article Affiliation country: Spain